Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.
Zhang L, Troccoli CI, Mateo-Victoriano B, Misiara Lincheta L, Jackson E, Shu P, Plastini T, Tao W, Kwon D, Chen XS, Sharma J, Jorda M, Kumar S, Lombard DB, Gulley JL, Bilusic M, Lockhart AC, Beuve A, Rai P.
Zhang L, et al. Among authors: shu p.
Cancer Res. 2024 Oct 10. doi: 10.1158/0008-5472.CAN-24-0133. Online ahead of print.
Cancer Res. 2024.
PMID: 39388307